Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex.

Baerlocher GM, Rovó A, Müller A, Matthey S, Stern M, Halter J, Heim D, Rischewski J, Gratwohl A, Tichelli A.

Blood. 2009 Jul 2;114(1):219-22. doi: 10.1182/blood-2009-03-209833. Epub 2009 May 1.

2.

Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.

Rovó A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M, Waltimo T, Studt JD, Tyndall A, Gratwohl A, Tichelli A.

Haematologica. 2011 Jan;96(1):150-5. doi: 10.3324/haematol.2010.030874. Epub 2010 Sep 17.

3.

Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Socié G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D.

Transplantation. 2001 Aug 27;72(4):699-706.

PMID:
11544434
4.

Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion.

de Pauw ES, Otto SA, Wijnen JT, Vossen JM, van Weel MH, Tanke HJ, Miedema F, Willemze R, Roelofs H, Fibbe WE.

Br J Haematol. 2002 Feb;116(2):491-6.

PMID:
11841457
5.

Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.

Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Schmitz M, Fischer J, Göbel U, Enczmann J, Dilloo D.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1338-45. Epub 2007 Sep 21.

6.

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.

Gallardo D, de la Cámara R, Nieto JB, Espigado I, Iriondo A, Jiménez-Velasco A, Vallejo C, Martín C, Caballero D, Brunet S, Serrano D, Solano C, Ribera JM, de la Rubia J, Carreras E.

Haematologica. 2009 Sep;94(9):1282-8. doi: 10.3324/haematol.2009.006924.

7.

Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation.

Lahav M, Uziel O, Kestenbaum M, Fraser A, Shapiro H, Radnay J, Szyper-Kravitz M, Avihai S, Hardan I, Shem-Tov N, Nagler A.

Transplantation. 2005 Oct 15;80(7):969-76.

PMID:
16249747
8.

Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.

Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C, Carmagnat M, Rocha V, Charron D, Socié G, Toubert A.

Blood. 2009 Jun 18;113(25):6477-84. doi: 10.1182/blood-2008-09-176594. Epub 2009 Mar 3.

9.

Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.

Hows JM, Passweg JR, Tichelli A, Locasciulli A, Szydlo R, Bacigalupo A, Jacobson N, Ljungman P, Cornish J, Nunn A, Bradley B, Socié G; IMUST Study Participating Centers; Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Bone Marrow Transplant. 2006 Dec;38(12):799-805. Epub 2006 Oct 30.

PMID:
17075568
10.

Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.

Lindemann M, Ottinger HD, Elmaagacli AH, Trenschel R, Rebmann V, Beelen DW, Grosse-Wilde H.

Exp Hematol. 2006 Dec;34(12):1753-8.

PMID:
17157173
11.

Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.

Giebel S, Nowak I, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Holowiecka-Goral A, Markiewicz M, Kopera M, Karolczyk A, Kyrcz-Krzemien S, Kusnierczyk P.

Eur J Haematol. 2009 Oct;83(4):343-56. doi: 10.1111/j.1600-0609.2009.01280.x. Epub 2009 Jun 2.

PMID:
19500138
12.

Telomere length changes in patients undergoing hematopoietic stem cell transplantation.

Lee J, Kook H, Chung I, Kim H, Park M, Kim C, Nah J, Hwang T.

Bone Marrow Transplant. 1999 Aug;24(4):411-5.

13.

Limited telomere shortening in hematopoietic stem cells after transplantation.

Brümmendorf TH, Rufer N, Baerlocher GM, Roosnek E, Lansdorp PM.

Ann N Y Acad Sci. 2001 Jun;938:1-7; discussion 7-8.

PMID:
11458496
14.

Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD.

Rovó A, Tichelli A, Passweg JR, Heim D, Meyer-Monard S, Holzgreve W, Gratwohl A, De Geyter C.

Blood. 2006 Aug 1;108(3):1100-5. Epub 2006 Mar 16.

15.

Changes of telomere length in children after hematopoietic stem cell transplantation.

Akiyama M, Hoshi Y, Sakurai S, Yamada H, Yamada O, Mizoguchi H.

Bone Marrow Transplant. 1998 Jan;21(2):167-71.

16.

IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.

Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.

Scand J Immunol. 2007 Dec;66(6):703-10.

17.

Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.

Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.

Transplantation. 2009 Dec 15;88(11):1261-72. doi: 10.1097/TP.0b013e3181bc267e.

PMID:
19996925
18.

Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.

Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL.

Biol Blood Marrow Transplant. 2006 Jul;12(7):758-69.

19.

IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.

Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A.

Hum Immunol. 2005 Jun;66(6):700-10. Epub 2005 Mar 19.

PMID:
15993715
20.

Supplemental Content

Support Center